Comparison of intravenous and subcutaneous exposure supporting dose selection of subcutaneous belimumab systemic lupus erythematosus Phase 3 program - Yapa, S Wickramaratne Senarath; Roth, D; Gordon, D; Struemper, H (Lupus, 2016)
Keywords: Administration, Intravenous; Antibodies, Monoclonal, Humanized - administration & dosage; Antibodies, Monoclonal, Humanized - pharmacokinetics; Clinical Trials, Phase I as Topic; Computer Simulation; Drug Administration Schedule; Female; Humans; Immunosuppressive Agents - administration & dosage; Immunosuppressive Agents - pharmacokinetics; Injections, Subcutaneous; Linear Models; Lupus; Lupus Erythematosus, Systemic - drug therapy; Male; Treatment Outcome; subcutaneous; pharmacokinetics; Systemic lupus erythematosus; intravenous; belimumab